menu search

LXXGF / LexaGene's MiQLab system successfully detects biohazard agents in US Army R&D test

LexaGene's MiQLab system successfully detects biohazard agents in US Army R&D test
LexaGene Holdings Inc (TSX-V:LXG, OTCQB:LXXGF)  announced that its MiQLab automated rapid pathogen testing device has successfully completed tests for biothreat agents including anthrax and plague as part of a research agreement with the US Army. MiQLab was used on reagents from the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense's (JPEO-CBRND) Joint Project Lead for CBRND Enabling Biotechnologies (JPL CBRND EB) Defense Biological Product Assurance Office (DBPAO) to successfully detect biothreat agents such as Bacillus anthracis and Yersinia pestis in under a minute, the company said. Read More
Posted: May 3 2022, 09:14
Author Name: Proactive Investors
Views: 102822

LXXGF News  

LexaGene Holdings announces MiQLab Systems sale to veterinary hospital in Wisconsin

By Proactive Investors
July 1, 2022

LexaGene Holdings announces MiQLab Systems sale to veterinary hospital in Wisconsin

LexaGene Holdings Inc (TSX-V:LXG, OTCQB:LXXGF) said it has entered into a purchase agreement with a veterinary hospital in Wisconsin. In a statement, more_horizontal

LexaGene reveals MiQLab Systems sale to large US veterinary corporation

By Proactive Investors
May 25, 2022

LexaGene reveals MiQLab Systems sale to large US veterinary corporation

LexaGene Holdings Inc (TSX-V:LXG, OTCQB:LXXGF) announced that a large veterinary animal health corporation has purchased two of LexaGene's MiQLab Sys more_horizontal

LexaGene's MiQLab system successfully detects biohazard agents in US Army R&D test

By Proactive Investors
May 3, 2022

LexaGene's MiQLab system successfully detects biohazard agents in US Army R&D test

LexaGene Holdings Inc (TSX-V:LXG, OTCQB:LXXGF)  announced that its MiQLab automated rapid pathogen testing device has successfully completed tests fo more_horizontal

LexaGene unveils advancements to its sample preparation cartridge for veterinary market

By Proactive Investors
March 29, 2022

LexaGene unveils advancements to its sample preparation cartridge for veterinary market

LexaGene Holdings Inc (TSX-V:LXG, OTCQB:LXXGF) has announced advancements to its sample preparation cartridge that improves its MiQLab System's abilit more_horizontal

LexaGene Holdings closes second tranche of $6.5M Meridian LGH investment

By Proactive Investors
February 18, 2022

LexaGene Holdings closes second tranche of $6.5M Meridian LGH investment

LexaGene Holdings Inc (TSX-V:LXG, OTCQB:LXXGF) announced it has closed the second tranche of its previously announced private placement to Meridian LG more_horizontal

LexaGene Holdings closes second tranche of $6.5M Meridian LGH investment

By Proactive Investors
February 18, 2022

LexaGene Holdings closes second tranche of $6.5M Meridian LGH investment

LexaGene Holdings Inc (TSX-V:LXG, OTCQB:LXXGF) announced it has closed the second tranche of its previously announced private placement to Meridian LG more_horizontal

LexaGene Holdings closes second tranche of $6.5M Meridian LGH investment

By Proactive Investors
February 18, 2022

LexaGene Holdings closes second tranche of $6.5M Meridian LGH investment

LexaGene Holdings Inc (TSX-V:LXG, OTCQB:LXXGF) announced it has closed the second tranche of its previously announced private placement to Meridian LG more_horizontal

LexaGene says Meridian LGH agrees to make an investment totaling C$6,475,000 in the company

By Proactive Investors
February 8, 2022

LexaGene says Meridian LGH agrees to make an investment totaling C$6,475,000 in the company

LexaGene Holdings Inc (TSX-V:LXG, OTCQB:LXXGF) said that Meridian LGH Holdings LLC has agreed to make an investment in LexaGene for a total of C$6,475 more_horizontal


Search within

Pages Search Results: